Recruiting studies: Psoriatic Arthritis Juvenile

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Phase 3 · 7 location(s) · Amgen · NCT05767047 Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
Phase N/A · 1 location(s) · Université Catholique de Louvain · NCT07000916 Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
Phase N/A · 1 location(s) · Pfizer · NCT05754710 Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620 A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With J
Phase 3 · 33 location(s) · AbbVie · NCT06100744 Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in
Phase 1 · 8 location(s) · Novartis Pharmaceuticals · NCT06751238 Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Phase 3 · 45 location(s) · Amgen · NCT04804553 A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With
Phase 3 · 47 location(s) · Bristol-Myers Squibb · NCT06869551 Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · 2 location(s) · University of Sao Paulo General Hospital · NCT07087912 Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Phase N/A · 82 location(s) · Duke University · NCT02418442 A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Phase 3 · 47 location(s) · Janssen Research & Development, LLC · NCT06663332 An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Acti
Phase 3 · 23 location(s) · UCB Biopharma SRL · NCT06668181 Pain in Inflammatory Joint Diseases
Phase N/A · 1 location(s) · Diakonhjemmet Hospital · NCT06718569 A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Phase 3 · 79 location(s) · Eli Lilly and Company · NCT03773965 Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Phase 2 · 1 location(s) · NYU Langone Health · NCT07138898

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.